SML1337

NQ301

≥98% (HPLC)

• Synonym(e): 2-Chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone, 2-[(4-Acetylphenyl)amino]-3-chloro-1,4-naphthalenedione, Compound 211, NQ 301
• Empirische Formel (Hill-System): C₂₃H₁₉N₃O · HBr
• CAS-Nummer: 130089-98-4
• Molekulargewicht: 434.33
• MDL-Nummer: MFCD00559986
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329825795
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: , faint red to dark red
• Löslichkeit: DMSO: 10 mg/mL, clear
• Lagertemp.: 2-8°C
• SMILES String: O=C1C(Cl)=C(NC2=CC=C(C(C)=O)C=C2)C(C3=CC=CC=C31)=O
• InChI: 1S/C18H12ClNO3/c1-10(21)11-6-8-12(9-7-11)20-16-15(19)17(22)13-4-2-3-5-14(13)18(16)23/h2-9,20H,1H3
• InChIKey: LSQZKIQSQHZVQS-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

NQ301 is an antithrombotic agent. Recent study shows that NQ301 (Compound 211) is a highly potent, selective, non-competitive allosteric inhibitor of CD45 that selectively inhibits dephosphorylation of substrate Lck pY-505 versus Lck pY-393. NQ301 prevents T cell receptor-mediated activation of Lck, Zap-70 and MAPK, and IL-2 production in primary T-cells. NQ301 exhibits immunosuppressive activity in mice.

NQ301 is an antithrombotic agent; antiplatelet; highly potent, selective non-competitive allosteric inhibitor of CD45.

Sicherheitshinweise

• Piktogramme: GHS07,GHS09
• Signalwort: Warning
• H-Sätze: H315,H319,H335,H400
• P-Sätze: P261 - P264 - P271 - P273 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Aquatic Acute 1 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable